More than 60 patients groups yesterday urged Congress to protect the 340B drug savings program. “We stand together to oppose any efforts to diminish the 340B program’s proven ability to help serve vulnerable patients and communities,” wrote the groups. “340B is vital to the health care safety net as it enables trusted community providers to fulfill their missions. In many communities – particularly low-income rural and urban areas – safety net providers are the sole pathways to affordable health care.”

Related News Articles

Headline
The Health Resources and Services Administration should increase its oversight of private nonprofit hospitals that participate in the 340B drug savings program…
Blog
The pharmaceutical industry’s latest “report” is an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices. The…
Blog
The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, continues to misrepresent a program with a more than 25-year…
Headline
The Centers for Medicare & Medicaid Services late today issued a final rule that increases Medicare hospital outpatient prospective payment system rates by…
Headline
The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act, H.R. 4538, bipartisan legislation that would limit the “orphan drug” exclusion…
Headline
The Centers for Medicare & Medicaid Services yesterday proposed surveying hospitals about their acquisition costs for specified covered outpatient…